Survival in progressive supranuclear palsy and frontotemporal dementia

Journal of Neurology, Neurosurgery and Psychiatry

Volumn 81, Issue 4, 2010, Pages 441-445

  Chiu, Wang Zheng ^a   Kaat, L D ^a   Seelaar, Harro ^a   Rosso, Sonia M ^a   Boon, Agnita J W ^a   Kamphorst, Wouter ^b   Van Swieten, John C ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

MAPT PROTEIN; PROTEIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; DEMOGRAPHY; DYING; FAMILY HISTORY; FEMALE; FRONTOTEMPORAL DEMENTIA; GENDER; GENE MUTATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PATHOLOGY; PICK PRESENILE DEMENTIA; PREDICTOR VARIABLE; PRIORITY JOURNAL; PROGNOSIS; PROGRESSIVE SUPRANUCLEAR PALSY; PROPORTIONAL HAZARDS MODEL; RISK; SCORING SYSTEM; SURVIVAL;

AGE OF ONSET; AGED; BRAIN; COGNITION DISORDERS; FEMALE; FRONTOTEMPORAL DEMENTIA; GENOTYPE; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEUROPSYCHOLOGICAL TESTS; PROGNOSIS; PROSPECTIVE STUDIES; SUPRANUCLEAR PALSY, PROGRESSIVE; SURVIVAL RATE; TAU PROTEINS; TIME FACTORS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 77950598486     PISSN: 00223050     EISSN: 1468330X     Source Type: Journal    
DOI: 10.1136/jnnp.2009.195719     Document Type: Article

References (41)

1. Steele JC, Richardson JC, Olszewski J. Progressive supranuclear palsy. A heterogeneous degeneration involving the brain stem, basal ganglia and cerebellum with vertical gaze and pseudobulbar palsy, nuchal dystonia and dementia. Arch Neurol 1964;10:333-59.
2. Litvan I, Agid Y, Calne D, et al. Clinical research criteria for the diagnosis of progressive supranuclear palsy (SteeleeRichardsoneOlszewski syndrome): report of the NINDS-SPSP international workshop. Neurology 1996;47:1-9.
3. Boeve BF. Links between frontotemporal lobar degeneration, corticobasal degeneration, progressive supranuclear palsy, and amyotrophic lateral sclerosis. Alzheimer Dis Assoc Disord 2007;21:S31-18.
4. Kertesz A, Munoz D. Relationship between frontotemporal dementia and corticobasal degeneration/progressive supranuclear palsy. Dement Geriatr Cogn Disord 2004;17:282-6.
5. Mackenzie IR, Neumann M, Bigio EH, et al. Nomenclature for neuropathologic subtypes of frontotemporal lobar degeneration: consensus recommendations. Acta Neuropathol 2009;117:15-18.
6. Donker Kaat L, Boon AJ, Kamphorst W, et al. Frontal presentation in progressive supranuclear palsy. Neurology 2007;69:723-9.
7. Wszolek ZK, Tsuboi Y, Uitti RJ, et al. Progressive supranuclear palsy as a disease phenotype caused by the S305S tau gene mutation. Brain 2001;124(Pt 8):1666-70.
8. Morris HR, Osaki Y, Holton J, et al. Tau exon 10 +16 mutation FTDP-17 presenting clinically as sporadic young onset PSP. Neurology 2003;61:102-4.
9. de Silva R, Lashley T, Strand C, et al. An immunohistochemical study of cases of sporadic and inherited frontotemporal lobar degeneration using 3R-and 4R-specific tau monoclonal antibodies. Acta Neuropathol 2006;111:329-40.
10. van Swieten J, Spillantini MG. Hereditary frontotemporal dementia caused by Tau gene mutations. Brain Pathol 2007;17:63-73.
11. Baker M, Litvan I, Houlden H, et al. Association of an extended haplotype in the tau gene with progressive supranuclear palsy. Hum Mol Genet 1999;8:711-15.
12. Borroni B, Grassi M, Agosti C, et al. Survival in frontotemporal lobar degeneration and related disorders: latent class predictors and brain functional correlates. Rejuvenation Res 2009;12:33-44.
13. Roberson ED, Hesse JH, Rose KD, et al. Frontotemporal dementia progresses to death faster than Alzheimer disease. Neurology 2005;65:719-25.
14. Hu WT, Parisi JE, Knopman DS, et al. Clinical features and survival of 3R and 4R tauopathies presenting as behavioral variant frontotemporal dementia. Alzheimer Dis Assoc Disord 2007;21:S39-43.
15. Kertesz A, McMonagle P, Blair M, et al. The evolution and pathology of frontotemporal dementia. Brain 2005;128(Pt 9):1996-2005.
16. Xie SX, Forman MS, Farmer J, et al. Factors associated with survival probability in autopsy-proven frontotemporal lobar degeneration. J Neurol Neurosurg Psychiatry 2008;79:126-9.
17. Testa D, Monza D, Ferrarini M, et al. Comparison of natural histories of progressive supranuclear palsy and multiple system atrophy. Neurol Sci 2001;22:247-51.
18. Papapetropoulos S, Gonzalez J, Mash DC. Natural history of progressive supranuclear palsy: a clinicopathologic study from a population of brain donors. Eur Neurol 2005;54:1-9.
19. Litvan I, Mangone CA, McKee A, et al. Natural history of progressive supranuclear palsy (SteeleeRichardsoneOlszewski syndrome) and clinical predictors of survival: a clinicopathological study. J Neurol Neurosurg Psychiatry 1996;60:615-20.
20. Nath U, Ben-Shlomo Y, Thomson RG, et al. Clinical features and natural history of progressive supranuclear palsy: a clinical cohort study. Neurology 2003;60:910-16.
21. Golbe LI, Ohman-Strickland PA. A clinical rating scale for progressive supranuclear palsy. Brain 2007;130(Pt 6):1552-65.
22. Josephs KA, Mandrekar JN, Dickson DW. The relationship between histopathological features of progressive supranuclear palsy and disease duration. Parkinsonism Relat Disord 2006;12:109-12.
23. Williams DR, Holton JL, Strand C, et al. Pathological tau burden and distribution distinguishes progressive supranuclear palsy-parkinsonism from Richardson's syndrome. Brain 2007;130(Pt 6):1566-76.
24. Hodges JR, Davies R, Xuereb J, et al. Survival in frontotemporal dementia. Neurology 2003;61:349-54.
25. Rosso SM, Donker Kaat L, Baks T, et al. Frontotemporal dementia in The Netherlands: patient characteristics and prevalence estimates from a population-based study. Brain 2003;126(Pt 9):2016-22.
26. Clinical and neuropathological criteria for frontotemporal dementia. The Lund and Manchester Groups. J Neurol Neurosurg Psychiatry 1994;57:416-18.
27. Williams DR, de Silva R, Paviour DC, et al. Characteristics of two distinct clinical phenotypes in pathologically proven progressive supranuclear palsy: Richardson's syndrome and PSP-parkinsonism. Brain 2005;128(Pt 6):1247-58.
28. Baker M, Mackenzie IR, Pickering-Brown SM, et al. Mutations in progranulin cause tau-negative frontotemporal dementia linked to chromosome 17. Nature 2006;442:916-19.
29. Rizzu P, Van Swieten JC, Joosse M, et al. High prevalence of mutations in the microtubule-associated protein tau in a population study of frontotemporal dementia in The Netherlands. Am J Hum Genet 1999;64:414-21.
30. Skibinski G, Parkinson NJ, Brown JM, et al. Mutations in the endosomal ESCRTIII-complex subunit CHMP2B in frontotemporal dementia. Nat Genet 2005;37:806-8.
31. Bronner IF, Rizzu P, Seelaar H, et al. Progranulin mutations in Dutch familial frontotemporal lobar degeneration. Eur J Hum Genet 2007;15:369-74.
32. Mata IF, Kachergus JM, Taylor JP, et al. Lrrk2 pathogenic substitutions in Parkinson's disease. Neurogenetics 2005;6:171-7.
33. Cairns NJ, Bigio EH, Mackenzie IR, et al. Neuropathologic diagnostic and nosologic criteria for frontotemporal lobar degeneration: consensus of the consortium for frontotemporal lobar degeneration. Acta Neuropathol 2007;114:5-22.
34. Litvan I, Hauw JJ, Bartko JJ, et al. Validity and reliability of the preliminary NINDS neuropathologic criteria for progressive supranuclear palsy and related disorders. J Neuropathol Exp Neurol 1996;55:97-105.
35. O'Sullivan SS, Massey LA, Williams DR, et al. Clinical outcomes of progressive supranuclear palsy and multiple system atrophy. Brain 2008;131(Pt 5):1362-72.
36. Larson EB, Shadlen MF, Wang L, et al. Survival after initial diagnosis of Alzheimer disease. Ann Intern Med 2004;140:501-9.
37. Post B, Merkus MP, de Haan RJ, et al. Prognostic factors for the progression of Parkinson's disease: a systematic review. Mov Disord 2007;22:1839-51; quiz 988.
38. Grasbeck A, Englund E, Horstmann V, et al. Predictors of mortality in frontotemporal dementia: a retrospective study of the prognostic influence of pre-diagnostic features. Int J Geriatr Psychiatry 2003;18:594-601.
39. Pasquier F, Richard F, Lebert F. Natural history of frontotemporal dementia: comparison with Alzheimer's disease. Dement Geriatr Cogn Disord 2004;17:253-7.
40. Seelaar H, Kamphorst W, Rosso SM, et al. Distinct genetic forms of frontotemporal dementia. Neurology 2008;71:1220-6.
41. Lopez OL, Litvan I, Catt KE, et al. Accuracy of four clinical diagnostic criteria for the diagnosis of neurodegenerative dementias. Neurology 1999;53:1292-9.